49 phenotypes from 6 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Bap1em1Test/Bap1+ involves: FVB	abnormal DNA methylation	J:213725
	abnormal epigenetic regulation of gene expression	J:213725
	normal hematopoietic system phenotype	J:213725
	increased colon tumor incidence	J:231692
	increased granulosa cell tumor incidence	J:231692
	increased incidence of tumors by chemical induction	J:213725
	increased lung carcinoma incidence	J:231692
	increased mammary adenocarcinoma incidence	J:231692
	increased mesothelioma incidence	J:231692
	increased ovary tumor incidence	J:231692
	increased skin tumor incidence	J:231692
	increased squamous cell carcinoma incidence	J:213725
Bap1em1Test/Bap1em1Test involves: FVB	embryonic lethality between implantation and placentation, complete penetrance	J:213725
Bap1em2Test/Bap1+ involves: FVB	increased granulosa cell tumor incidence	J:231692
	increased incidence of tumors by chemical induction	J:231692
	increased lung carcinoma incidence	J:231692
	increased mammary adenocarcinoma incidence	J:231692
	increased mesothelioma incidence	J:231692
	increased ovary tumor incidence	J:231692
	increased pancreatic islet cell carcinoma incidence	J:231692
	increased skin tumor incidence	J:231692
Bap1em3Test/Bap1+ involves: FVB	increased granulosa cell tumor incidence	J:231692
	increased incidence of tumors by chemical induction	J:231692
	increased lung carcinoma incidence	J:231692
	increased lymphoma incidence	J:231692
	increased mammary adenocarcinoma incidence	J:231692
	increased ovary tumor incidence	J:231692
	increased skin tumor incidence	J:231692
Bap1tm1.1Geno/Bap1+ Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+ involves: C57BL/6 * C57BL/6NTac	abnormal hematopoietic system morphology/development	J:187380
Bap1tm1.1Geno/Bap1tm1.1Geno Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+ involves: C57BL/6 * C57BL/6NTac	abnormal bone marrow cell physiology	J:187380
	abnormal cardiac thrombosis	J:187380
	abnormal erythrocyte morphology	J:187380
	abnormal erythropoiesis	J:187380
	abnormal granulocyte morphology	J:187380
	abnormal hematopoietic stem cell physiology	J:187380
	abnormal myelopoiesis	J:187380
	abnormal neutrophil morphology	J:187380
	anemia	J:187380
	anisopoikilocytosis	J:187380
	cardiac muscle necrosis	J:187380
	enlarged spleen	J:187380
	extramedullary hematopoiesis	J:187380
	giant platelets	J:187380
	heart inflammation	J:187380
	increased hematopoietic stem cell number	J:187380
	increased leukemia incidence	J:187380
	increased leukocyte cell number	J:187380
	increased monocyte cell number	J:187380
	increased neutrophil cell number	J:187380
	increased nucleated erythrocyte cell number	J:187380
	myeloid hyperplasia	J:187380
	thrombocytopenia	J:187380
Bap1tm1.2Geno/Bap1tm1.2Geno involves: C57BL/6	embryonic growth retardation	J:187380
	embryonic lethality during organogenesis, complete penetrance	J:187380
Bap1tm1a(EUCOMM)Hmgu/Bap1+ C57BL/6N-Bap1tm1a(EUCOMM)Hmgu/Wtsi	abnormal vibrissa morphology	J:211773
Bap1tm1a(EUCOMM)Hmgu/Bap1tm1a(EUCOMM)Hmgu C57BL/6N-Bap1tm1a(EUCOMM)Hmgu/Wtsi	abnormal chorion morphology	J:261316
	abnormal placenta morphology	J:261316
	abnormal trophoblast layer morphology	J:261316
	abnormal visceral yolk sac morphology	J:261316
	embryonic lethality during organogenesis, incomplete penetrance	J:261316
	lethality throughout fetal growth and development, complete penetrance	J:261316
	preweaning lethality, complete penetrance	J:211773